GLP-1s and Cancer: Meta-analysis Shows Little or No Link
The systematic review and meta-analysis of 48 trials involving 94,245 individuals show little or no effect of GLP-1 RA treatment on the risk for obesity-related cancers. Medscape Medical News
SOLVD Health Advances Development of Novel Test to Optimize GLP-1 Therapeutic Response
SAN DIEGO–(BUSINESS WIRE)–SOLVD Health, a patient intelligence company developing cutting-edge precision solutions to deliver better health outcomes, today announced the launch of two studies to validate its innovative GLP-1 patient stratification diagnostic platform. These studies aim to transform obesity and type 2 diabetes care by enabling healthcare providers to identify individuals most likely to benefit […]
Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Limited (02196.HK and 600106.SH), a leading innovation-driven global healthcare company, for the development, manufacturing and commercialization of YP05002, a small molecule glucagon-like peptide 1 (GLP-1) receptor […]
Wall Street Remains Cautious on Molson Coors Beverage Company (TAP)
Molson Coors Beverage Company (NYSE:TAP) is among the Top 15 Lowest P/E Ratios of the S&P 500 in 2025. On November 21, Piper Sandler lowered its price target for the stock to $50 from $52, while keeping a Neutral rating. The firm said it was revising its price target, taking into account recent developments in […]
Pfizer to pay $150M upfront for small molecule GLP-1 from Fosun subsidiary
On Nov. 19, Pfizer CFO Dave Denton said at the Jefferies Global Healthcare Conference that the large pharma was still looking for an oral small molecule for obesity and that it was …
Anemia: A Lesser-Known Side Effect of GLP-1 Drugs?
With the skyrocketing popularity of GLP-1 RAs, some lesser-known side effects, including anemia, are coming to light. Medscape Medical News
GLP-1 Inquiries: Key Points for PCPs and College Students
College students may seek you out over winter break wanting to start a GLP-1. Medscape Medical News
Structure Therapeutics Inc. (GPCR) Discusses Topline Results from ACCESS Program of Oral Small Molecule GLP-1 Receptor Agonist – Slideshow
Metabolic benefits of 1,3-diacylglycerol in type 2 diabetes mellitus and its association with gut microbiota-derived SCFAs-GPR41-GLP-1 signaling
Food Funct., 2026, Accepted ManuscriptDOI: 10.1039/D5FO03164H, Paper Jiaomei Li, Hao Wang, Jiekai Yang, Yicheng Wang, Guo Jia, Jiaojiao Gu1,3-Diacylglycerol (1,3-DAG) is a dietary lipid with known lipid-lowering effects, yet its role in type 2 diabetes mellitus (T2DM) and gut microbiota regulation remains unclear. This study investigated the effects…The content of this RSS Feed (c) The […]
GLP-1 drugs have ‘little or no effect’ on risk of obesity-related cancers, study suggests
Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related cancers, new research suggests.